Results 31 to 40 of about 2,971 (159)

A Potential Serum Biomarker for Screening Lung Cancer Risk in High Level Environmental Radon Areas: A Pilot Study

open access: yesLife, 2021
Radon is a major cause of lung cancer (LC) deaths among non-smokers worldwide. However, no serum biomarker for screening of LC risk in high residential radon (HRR) areas is available. Therefore, the aim of this study was to determine diagnostic values of
Narongchai Autsavapromporn   +7 more
doaj   +1 more source

CYFRA21-1 levels could be a biomarker for bladder cancer: a meta-analysis

open access: yesGenetics and Molecular Research, 2015
The proteolytic region of cytokeratin-19, referred to as CYFRA21-1, is a soluble molecule present in the serum and other body fluids, and is considered a tumor marker in several neoplastic diseases. To examine whether urinary or serum samples containing CYFRA21-1 can be used as biomarkers for bladder cancer, we conducted a comprehensive meta-analysis ...
L I, Kuang   +4 more
openaire   +2 more sources

Mechanisms of the release of CYFRA21-1 in human lung cancer cell lines

open access: yesLung Cancer, 2000
The CYFRA 21-1 assay which detects cytokeratin 19 (CK19) fragment is widely used as a tumor marker for lung cancer. However, the reason why some lung cancer cell lines release CK19 fragment in culture supernatants and others do not, remains unclear. It was hypothesized that the release of CK19 fragment may be elucidated by the expression of mRNA for ...
K, Dohmoto   +8 more
openaire   +3 more sources

Real‐World Prognostic Analysis of Clinical Characteristics in Extensive‐Stage Small Cell Lung Cancer: A Nomogram for Survival Prediction in Patients Receiving First‐Line Immunochemotherapy With Serplulimab

open access: yesCancer Medicine, Volume 15, Issue 8, August 2026.
Among 239 patients reviewed, 109 patients with extensive‐stage small‐cell lung cancer receiving first‐line serplulimab‐based immunochemotherapy were included. A nomogram incorporating liver metastasis, maintenance therapy, albumin, and neutrophil‐to‐lymphocyte ratio predicted overall survival and significantly stratified patients into three risk groups
Ying Zhu   +6 more
wiley   +1 more source

Too Old for Surgery? A Case Report of an Octogenarian Patient With Locally Advanced Lung Cancer Achieving Long‐Term Survival via Bilobectomy Followed by Adjuvant Targeted Therapy

open access: yesCancer Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background An increasing number of octogenarian patients are being diagnosed with lung cancer, but they are less likely to receive surgery because of fragility. As a result, the optimal management of lung cancer in octogenarians remains unclear.
Han‐Yu Deng   +3 more
wiley   +1 more source

Y Chromosome Haplogroups and Susceptibility to Esophageal Squamous Cell Carcinoma: An Exploratory Association and Diagnostic Modeling Study

open access: yesMolecular Genetics &Genomic Medicine, Volume 14, Issue 8, August 2026.
The exploratory study examined whether Y chromosome haplogroups are potentially associated with ESCC in a male Chinese cohort. O2a1b and O1b1a showed nominal differences between patients and controls, but these signals were not robust after FDR correction. RNA‐seq suggested possible biological differences, which require validation in larger independent
Xueji Shi   +7 more
wiley   +1 more source

A Review of Breath Sensing for Disease Monitoring and Diagnosis: Breathomics, Artificial Intelligence, and Nanomaterials for the Future of Medicine

open access: yesAdvanced Sensor Research, Volume 5, Issue 7, July 2026.
Breathomics is established as a non‐invasive diagnostic strategy by combining volatile organic compound biomarkers, nanomaterial‐based sensor arrays, and AI‐driven classification. Key diseases, sensing materials, and analytical challenges are critically compared, revealing how portable, data‐enabled breath platforms are moving toward clinically useful ...
Anesu Nyabadza   +3 more
wiley   +1 more source

Unlocking the Full Potential of Immunotherapy: Visualizing and Remodeling the Tumor Immune Microenvironment With Aggregation‐Induced Emission Luminogens

open access: yesAggregate, Volume 7, Issue 7, July 2026.
An AIEgen‐based immunotherapy paradigm that integrates rational photophysical engineering, high‐fidelity interrogation of immune–tumor interactions, and synergistic tumor immune microenvironment (TIME) remodeling is highlighted. Recent progress in molecular design, immune imaging, and combinational therapeutic strategies is summarized, together with ...
Xiangyu Tan   +8 more
wiley   +1 more source

Preoperative Cyfra21-1 and SCC-Ag serum titers predict survival in patients with stage II esophageal squamous cell carcinoma

open access: yesJournal of Translational Medicine, 2012
Background The purpose of this study is to evaluate the predictive significance of preoperative serum level of cytokeratin 19 fragments (Cyfra21-1) and squamous cell carcinoma antigen (SCC-Ag) after complete resection in patients with stage II esophageal
Cao Xun   +7 more
doaj   +1 more source

Unlocking the Potential of MXene‐Based Electrochemical Biosensors: A Review of Biofunctionalization Strategies and Biosensing Principles

open access: yesAdvanced Materials Technologies, Volume 11, Issue 12, 18 June 2026.
ABSTRACT Electrochemical biosensors enable the accurate and timely detection of clinical biomarkers, improving healthcare and precision medicine. MXene nanosheets, a class of 2D transition metal carbides, nitrides, and carbonitrides, are promising materials for developing next‐generation electrochemical biosensors due to their unique physicochemical ...
Muhsin Ali   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy